Clinitech Laboratory Ltd

Clinitech Laboratory Ltd

$CTLLABHealthcare Service ProviderBSE

Clinitech Laboratory Ltd (CTLLAB) last traded at ₹35.5, a market capitalisation of ₹8.1 crore, on a P/E of 19.3. Over the past 52 weeks the stock has ranged between ₹28.6 and ₹57. Clinitech Laboratory Ltd last reported results for the quarter ended Mar 2026, with sales of ₹4.41 crore and net profit of ₹0.12 crore. Clinitech Laboratory Ltd’s annual general meeting is scheduled for 24 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Clinitech Laboratory Ltd share price and key metrics

Current price
₹35.5
Market cap
₹8.1 cr
Stock P/E
19.3
Book value
₹40.5
ROE
4.65%
ROCE
7.20%
Dividend yield
0.00%
52w high / low
57.0/28.6

Metrics as of 25 Aug 2026. Not real time.

Clinitech Laboratory Ltd quarterly results

Clinitech Laboratory Ltd consolidated quarterly results, figures in ₹ crore
₹ croreMar 2025Sep 2025Mar 2026
Sales4.165.084.41
Expenses3.884.543.96
Operating profit0.280.540.45
OPM %6.73%10.63%10.20%
Other income0.170.110.08
Interest0.020.050.02
Depreciation0.140.250.26
Profit before tax0.290.350.25
Tax %41.38%14.29%52.00%
Net profit0.170.30.12
EPS (₹)0.741.310.53

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Clinitech Laboratory Ltd annual results

Clinitech Laboratory Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2025Mar 2026
Sales8.239.49
Operating profit0.830.99
OPM %10.09%10.43%
Net profit0.390.42
EPS (₹)1.711.84

TTM is the trailing twelve months to the most recent quarter.

Clinitech Laboratory Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
%
TTM
15%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
%
TTM
8%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
-32%
Return on Equity
10 Years
%
5 Years
%
3 Years
%
Last Year
5%

Clinitech Laboratory Ltd shareholding pattern

Promoters held 64.21% at Mar 2026, up from 61.58% at Sep 2024. FIIs 0.32%.

Clinitech Laboratory Ltd shareholding pattern by quarter, in percent
% heldSep 2024Mar 2025Sep 2025Mar 2026
Promoters61.58%61.58%62.42%64.21%
FIIs0.32%0.32%0.32%0.32%
Public38.11%38.11%37.27%35.49%
No. of shareholders346303303297

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Clinitech Laboratory Ltd’s AGM?

Clinitech Laboratory Ltd’s annual general meeting is scheduled for 24 Sept 2026.

  • AGM16th Annual General Meeting to adopt financial statements and re-appoint director

See the full results calendar for every Indian company reporting in the next 30 days.

Clinitech Laboratory Ltd corporate filings

  • We are enclosing herewith copy of newspaper advertisement w.r.t Notice and e-voting for Annual General Meeting to be held on Thursday, September 24, 2026 at 11.30 A.M through video conferening, ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Clinitech Laboratory Ltd has issued a newspaper advertisement regarding its upcoming…

    Read the full analysis
  • Date of 16th AGM: September 24, 2026 Book Closure Dates: September 18, 2026 to September 24, 2026 (both days inclusive).Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Clinitech Laboratory Limited has formally intimated the schedule for its 16th Annual…

    Read the full analysis
  • Annual Report for thr FY 2025-26 along with Notice of AGM and all annexures theretoOthersmedium impact
    Filing PDF

    Cruxal's analysis: Clinitech Laboratory Limited has scheduled its 16th Annual General Meeting for September…

    Read the full analysis
  • We hereby inform that the Board of Directors of the company, at its meeting held today i.e., August 17, 2026, for which intimation was already given, have: Approved appointment of director ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Clinitech Laboratory Limited has announced the outcome of its board meeting held on…

    Read the full analysis
  • Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Clinitech Laboratory Limited has issued an intimation for a Board of Directors meeting…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Clinitech Laboratory Ltd

Cruxal reads every Clinitech Laboratory Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.